Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004761627> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3004761627 abstract "36 Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Head and Neck cancers are based on IHC based detection of PD-L1 expression in tumor tissue. Invasive biopsy to obtain tumor tissue for IHC is associated with procedural risks, sequelae and expenses. Prior efforts at PD-L1 profiling of Circulating Tumor Cells (CTCs) have been constrained by low CTC yields. We employed a novel approach for harvesting sufficient CTCs from Head and Neck cancers that permit PD-L1 profiling by Immunocytochemistry (ICC). Methods: 15 ml peripheral blood was collected from 95 patients with head and neck squamous cell carcinomas (HNSCC). CTCs were enriched from PBMCs via an epigenetically acting stabilization process which induced apoptosis in non-malignant cells and conferred survival privilege on apoptosis-resistant CTCs, which were harvested and confirmed by immunostaining for EpCAM and pan-CK. Deep ICC profiling of CTCs was performed with organ-specific markers as well as PD-L1:22c3 and PD-L1:28-8 clones. Results: Viable CTCs could be enriched and harvested in 90 out of 95 samples (95.3%) regardless of metastatic or treatment status. Deep ICC and PD-L1 profiling could be performed in all 90 samples (100%). PD-L1 expression was quantitatively assigned as ‘Low’, ‘Moderate’ or ‘High’. 28 (31.1%) samples were positive for PD-L1:28-8 (27 Low + 1 Moderate) and 26 (28.9%) samples were positive for PD-L1:22c3 (24 Low + 2 Moderate). 15 samples were positive for both PD-L1 clones. Conclusions: CTCs in Head and Neck squamous cell carcinomas can be considered for evaluating PD-L1 expression in patients where ICI therapies are otherwise viable." @default.
- W3004761627 created "2020-02-14" @default.
- W3004761627 creator A5009096856 @default.
- W3004761627 creator A5013378861 @default.
- W3004761627 creator A5015926221 @default.
- W3004761627 creator A5032936077 @default.
- W3004761627 creator A5033322859 @default.
- W3004761627 creator A5043873076 @default.
- W3004761627 creator A5047835983 @default.
- W3004761627 creator A5047983896 @default.
- W3004761627 creator A5057697338 @default.
- W3004761627 creator A5066498912 @default.
- W3004761627 creator A5083797029 @default.
- W3004761627 creator A5087494976 @default.
- W3004761627 date "2020-02-10" @default.
- W3004761627 modified "2023-09-27" @default.
- W3004761627 title "PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers." @default.
- W3004761627 doi "https://doi.org/10.1200/jco.2020.38.5_suppl.36" @default.
- W3004761627 hasPublicationYear "2020" @default.
- W3004761627 type Work @default.
- W3004761627 sameAs 3004761627 @default.
- W3004761627 citedByCount "0" @default.
- W3004761627 crossrefType "journal-article" @default.
- W3004761627 hasAuthorship W3004761627A5009096856 @default.
- W3004761627 hasAuthorship W3004761627A5013378861 @default.
- W3004761627 hasAuthorship W3004761627A5015926221 @default.
- W3004761627 hasAuthorship W3004761627A5032936077 @default.
- W3004761627 hasAuthorship W3004761627A5033322859 @default.
- W3004761627 hasAuthorship W3004761627A5043873076 @default.
- W3004761627 hasAuthorship W3004761627A5047835983 @default.
- W3004761627 hasAuthorship W3004761627A5047983896 @default.
- W3004761627 hasAuthorship W3004761627A5057697338 @default.
- W3004761627 hasAuthorship W3004761627A5066498912 @default.
- W3004761627 hasAuthorship W3004761627A5083797029 @default.
- W3004761627 hasAuthorship W3004761627A5087494976 @default.
- W3004761627 hasConcept C121608353 @default.
- W3004761627 hasConcept C126322002 @default.
- W3004761627 hasConcept C142724271 @default.
- W3004761627 hasConcept C143998085 @default.
- W3004761627 hasConcept C204232928 @default.
- W3004761627 hasConcept C2776530083 @default.
- W3004761627 hasConcept C2776833033 @default.
- W3004761627 hasConcept C2777701055 @default.
- W3004761627 hasConcept C2779013556 @default.
- W3004761627 hasConcept C2781053074 @default.
- W3004761627 hasConcept C4224716 @default.
- W3004761627 hasConcept C502942594 @default.
- W3004761627 hasConcept C61238886 @default.
- W3004761627 hasConcept C71924100 @default.
- W3004761627 hasConceptScore W3004761627C121608353 @default.
- W3004761627 hasConceptScore W3004761627C126322002 @default.
- W3004761627 hasConceptScore W3004761627C142724271 @default.
- W3004761627 hasConceptScore W3004761627C143998085 @default.
- W3004761627 hasConceptScore W3004761627C204232928 @default.
- W3004761627 hasConceptScore W3004761627C2776530083 @default.
- W3004761627 hasConceptScore W3004761627C2776833033 @default.
- W3004761627 hasConceptScore W3004761627C2777701055 @default.
- W3004761627 hasConceptScore W3004761627C2779013556 @default.
- W3004761627 hasConceptScore W3004761627C2781053074 @default.
- W3004761627 hasConceptScore W3004761627C4224716 @default.
- W3004761627 hasConceptScore W3004761627C502942594 @default.
- W3004761627 hasConceptScore W3004761627C61238886 @default.
- W3004761627 hasConceptScore W3004761627C71924100 @default.
- W3004761627 hasLocation W30047616271 @default.
- W3004761627 hasOpenAccess W3004761627 @default.
- W3004761627 hasPrimaryLocation W30047616271 @default.
- W3004761627 hasRelatedWork W11093380 @default.
- W3004761627 hasRelatedWork W14071285 @default.
- W3004761627 hasRelatedWork W17968176 @default.
- W3004761627 hasRelatedWork W20900819 @default.
- W3004761627 hasRelatedWork W4080508 @default.
- W3004761627 hasRelatedWork W4832487 @default.
- W3004761627 hasRelatedWork W5797558 @default.
- W3004761627 hasRelatedWork W6442918 @default.
- W3004761627 hasRelatedWork W8454978 @default.
- W3004761627 hasRelatedWork W2758172 @default.
- W3004761627 isParatext "false" @default.
- W3004761627 isRetracted "false" @default.
- W3004761627 magId "3004761627" @default.
- W3004761627 workType "article" @default.